Hormone-refractory prostate cancer+1
Not yet recruitingSafety and Efficacy of GSK5764227 with Abiraterone Acetate and Enzalutamide in Metastatic Castration‑Resistant Prostate Cancer Patients
Safety and Efficacy of GSK5764227 with Abiraterone Acetate and Enzalutamide in Metastatic Castration‑Resistant Prostate Cancer Patients
- Disease:Hormone-refractory prostate cancerProstate cancer
- Substances:Abiraterone AcetateEnzalutamide+1
Germany- Participants:18–64 years · 65+ years
- Substances:Abiraterone Acetate
- Sponsor:Glaxosmithkline Research & Development Limited











